Evaluation of a New CZT System
- Conditions
- Parathyroid AdenomaThyroid Adenoma
- Registration Number
- NCT01084356
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Brief Summary
The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.
Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.
The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- age over 18
Exclusion Criteria
- pregnancy
- patients unable to understand and sign an informed consent
- age under 18
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center
🇮🇱Tel Aviv, Israel
Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center🇮🇱Tel Aviv, IsraelEinat Even Sapir, PhD, MDContact972-3-6974444evensap@tasmc.health.gov.ilAyelet Kurzband, BAContact972-3-6974444ayeletk@tasmc.health.gov.ilHedva Lerman, MDSub InvestigatorEinat Even-Sapir, MD, PhDPrincipal Investigator